Patents by Inventor Jeremy BOYETTE
Jeremy BOYETTE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11957586Abstract: Devices, systems and methods for altering functioning of a tissue/organ by application of force thereto. In one preferred embodiment, a device for reducing or preventing regurgitation of blood through a valve of a heart is provided. A device may include a main body having a segment adapted to apply force to a surface of tissue/organ and a member that applies counterforce to the force applied by the segment. Kits are provided in which devices having varying lengths and widths can be selected for the best fit for a particular location of treatment. A width sizing instrument may be provided. A length sizing instrument may be provided. A separate sleeve and/or pad may be provided which may be first anchored to the tissue/organ before fixing the device thereto.Type: GrantFiled: January 25, 2019Date of Patent: April 16, 2024Assignee: Mitre Medical Corp.Inventors: Evan Anderson, John MacMahon, Jeremy Boyette, Christopher Pell, Michael Stewart, Mark Juravic
-
Publication number: 20230225903Abstract: Described are implantable devices having reservoirs for the sustained release of therapeutic agents. The devices are configured to be at least partially implanted in an eye and include a retention structure and a penetrable element coupled to and extending within at least a portion of the proximal end region of the device. The device includes a porous drug release element is positioned in fluid communication with an outlet of the device and a reservoir having a volume configured to contain one or more therapeutic agents in fluid communication with the outlet through the porous drug release element. The device is at least partially inserted along an axis of insertion.Type: ApplicationFiled: February 14, 2023Publication date: July 20, 2023Inventors: Randolph E. Campbell, Kevin W. Sacheman, Bradley G. Bachelder, Signe Erickson, Jeremy Boyette
-
Patent number: 11617680Abstract: An implantable device having a reservoir for the sustained release of therapeutic agents. The device is configured to be at least partially implanted in an eye and include a retention structure and a penetrable element coupled to and extending within at least a portion of the proximal end region of the device. The device includes a porous drug release element is positioned in fluid communication with an outlet of the device and a reservoir having a volume configured to contain one or more therapeutic agents in fluid communication with the outlet through the porous drug release element. The device is at least partially inserted along an axis of insertion.Type: GrantFiled: April 5, 2017Date of Patent: April 4, 2023Assignee: ForSight Vision4, Inc.Inventors: Randolph E. Campbell, Kevin W. Sacherman, Bradley G. Bachelder, Signe Erickson, Jeremy Boyette
-
Publication number: 20230072346Abstract: A therapeutic device for extended release drug delivery including a refillable reservoir configured to receive a therapeutic agent and having an outlet for delivery of the therapeutic agent to a patient from the reservoir over an extended period. A porous structure is coupled near the outlet of the reservoir, the porous structure formed of sintered material. A barrier layer is coupled to the reservoir on or adjacent a surface of the porous structure such that the therapeutic agent passes through both the porous structure and the barrier layer upon delivery from the reservoir through the outlet. The porous structure is tuned to deliver the therapeutic agent at a diffusion rate and the barrier layer is adapted to block passage of particles having an average particle size within an average particle size range that is outside an average particle size range blocked by the porous structure. Related methods and systems are provided.Type: ApplicationFiled: July 29, 2022Publication date: March 9, 2023Inventors: Randolph E. Campbell, Kevin W. Sacherman, Kathleen Cogan Farinas, Signe Erickson, Jeremy Boyette
-
Patent number: 11432959Abstract: A therapeutic device for extended release drug delivery including a refillable reservoir configured to receive a therapeutic agent and having an outlet for delivery of the therapeutic agent to a patient from the reservoir over an extended period. A porous structure is coupled near the outlet of the reservoir, the porous structure formed of sintered material. A barrier layer is coupled to the reservoir on or adjacent a surface of the porous structure such that the therapeutic agent passes through both the porous structure and the barrier layer upon delivery from the reservoir through the outlet. The porous structure is tuned to deliver the therapeutic agent at a diffusion rate and the barrier layer is adapted to block passage of particles having an average particle size within an average particle size range that is outside an average particle size range blocked by the porous structure. Related methods and systems are provided.Type: GrantFiled: November 18, 2016Date of Patent: September 6, 2022Assignee: ForSight Vision4, Inc.Inventors: Randolph E. Campbell, Kevin W. Sacherman, Kathleen Cogan Farinas, Signe Erickson, Jeremy Boyette
-
Patent number: 11399941Abstract: Devices, systems and methods for altering functioning of a tissue/organ by application of force thereto. In one preferred embodiment, a device for reducing or preventing regurgitation of blood through a valve of a heart is provided. A device may include a main body having a segment adapted to apply force to a surface of tissue/organ; a member that applies counterforce to the force applied by the segment; and an adjuster that is manually operable to change the force applied by the segment. The adjuster can be manually operated before or after anchoring of the device to the tissue/organ.Type: GrantFiled: January 25, 2019Date of Patent: August 2, 2022Assignee: Mitre Medical Corp.Inventors: John MacMahon, Evan Anderson, Jeremy Boyette
-
Publication number: 20210290392Abstract: An epicardial device for reducing or preventing regurgitation of blood through a valve of a heart includes a main body having a segment adapted to apply force to an epicardial surface of the heart. A member that applies counterforce to the force applied by the segment is also provided. A foundation is configured to be anchored to the epicardial surface of the heart. The foundation includes a surface configured with attachment features. The device further includes a surface configured with mating attachment features configured to attach to the attachment features of the foundation. The mating attachment features and attachment features are separable and reattachable to allow repositioning of at least a portion of the device relative to the foundation.Type: ApplicationFiled: June 9, 2021Publication date: September 23, 2021Inventors: John MacMahon, Evan Anderson, Jeremy Boyette
-
Patent number: 11058540Abstract: An epicardial device for reducing or preventing regurgitation of blood through a valve of a heart includes a main body having a segment adapted to apply force to an epicardial surface of the heart. A member that applies counterforce to the force applied by the segment is also provided. A foundation is configured to be anchored to the epicardial surface of the heart. The foundation includes a surface configured with attachment features. The device further includes a surface configured with mating attachment features configured to attach to the attachment features of the foundation. The mating attachment features and attachment features are separable and reattachable to allow repositioning of at least a portion of the device relative to the foundation.Type: GrantFiled: January 25, 2019Date of Patent: July 13, 2021Assignee: Mitre Medical Corp.Inventors: John MacMahon, Evan Anderson, Jeremy Boyette
-
Publication number: 20210205130Abstract: A therapeutic device for extended release drug delivery including a refillable reservoir configured to receive a therapeutic agent and having an outlet for delivery of the therapeutic agent to a patient from the reservoir over an extended period. A porous structure is coupled near the outlet of the reservoir, the porous structure formed of sintered material. A barrier layer is coupled to the reservoir on or adjacent a surface of the porous structure such that the therapeutic agent passes through both the porous structure and the barrier layer upon delivery from the reservoir through the outlet. The porous structure is tuned to deliver the therapeutic agent at a diffusion rate and the barrier layer is adapted to block passage of particles having an average particle size within an average particle size range that is outside an average particle size range blocked by the porous structure. Related methods and systems are provided.Type: ApplicationFiled: November 18, 2016Publication date: July 8, 2021Applicant: ForSight Vision4, Inc.Inventors: Randolph E. CAMPBELL, Kevin W. SACHERMAN, Kathleen Cogan FARINAS, Signe ERICKSON, Jeremy BOYETTE
-
Publication number: 20210045878Abstract: Devices, systems and methods for altering functioning of a tissue/organ by application of force thereto. In one preferred embodiment, a device for reducing or preventing regurgitation of blood through a valve of a heart is provided. A device may include a main body having a segment adapted to apply force to a surface of tissue/organ and a member that applies counterforce to the force applied by the segment. Kits are provided in which devices having varying lengths and widths can be selected for the best fit for a particular location of treatment. A width sizing instrument may be provided. A length sizing instrument may be provided. A separate sleeve and/or pad may be provided which may be first anchored to the tissue/organ before fixing the device thereto.Type: ApplicationFiled: January 25, 2019Publication date: February 18, 2021Inventors: Evan Anderson, John MacMahon, Jeremy Boyette, Christopher Pell, Michael Stewart, Mark Juravic
-
Publication number: 20190231527Abstract: Devices, systems and methods for altering functioning of a tissue/organ by application of force thereto. In one preferred embodiment, a device for reducing or preventing regurgitation of blood through a valve of a heart is provided. A device may include a main body having a segment adapted to apply force to a surface of tissue/organ; a member that applies counterforce to the force applied by the segment; and an adjuster that is manually operable to change the force applied by the segment. The adjuster can be manually operated before or after anchoring of the device to the tissue/organ.Type: ApplicationFiled: January 25, 2019Publication date: August 1, 2019Inventors: John MacMahon, Evan Anderson, Jeremy Boyette
-
Publication number: 20190231528Abstract: An epicardial device for reducing or preventing regurgitation of blood through a valve of a heart includes a main body having a segment adapted to apply force to an epicardial surface of the heart. A member that applies counterforce to the force applied by the segment is also provided. A foundation is configured to be anchored to the epicardial surface of the heart. The foundation includes a surface configured with attachment features. The device further includes a surface configured with mating attachment features configured to attach to the attachment features of the foundation. The mating attachment features and attachment features are separable and reattachable to allow repositioning of at least a portion of the device relative to the foundation.Type: ApplicationFiled: January 25, 2019Publication date: August 1, 2019Inventors: John MacMahon, Evan Anderson, Jeremy Boyette
-
Publication number: 20190117454Abstract: Described are implantable devices having reservoirs for the sustained release of therapeutic agents. The devices are configured to be at least partially implanted in an eye and include a retention structure and a penetrable element coupled to and extending within at least a portion of the proximal end region of the device. The device includes a porous drug release element is positioned in fluid communication with an outlet of the device and a reservoir having a volume configured to contain one or more therapeutic agents in fluid communication with the outlet through the porous drug release element. The device is at least partially inserted along an axis of insertion.Type: ApplicationFiled: April 5, 2017Publication date: April 25, 2019Inventors: Randolph E. Campbell, Kevin W. Sacherman, Bradley G. Bachelder, Signe Erickson, Jeremy Boyette
-
Publication number: 20180055660Abstract: Wearable devices for spinal deformities, including a wearable brace configured to be worn about a patient's torso, at least one inflation bladder carried directly or indirectly by an inner surface of the brace, and positioned such that inflation of the bladder with a fluid applies a pressure to generate a force on the patient at a targeted location, at least one force sensor carried directly or indirectly by a surface of the brace, to measure the force independent of the bladder, and the force sensor adapted to output a signal indicative of a force applied on the sensor.Type: ApplicationFiled: October 24, 2017Publication date: March 1, 2018Inventors: John MACMAHON, Luke STIKELEATHER, Tom SAUL, Jeremy BOYETTE